|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
REGDANVIMAB |
J06BD06 |
RO
|
Not authorised
|
21-11-2022 |
|
|
VALID
|
|
RIPRETINIB |
L01EX19 |
RO
|
Not authorised
|
21-11-2022 |
|
|
VALID
|
|
SOTROVIMAB |
J06BD05 |
RO
|
Not authorised
|
21-11-2022 |
|
|
VALID
|
|
TECOVIRIMAT |
J05AX24 |
RO
|
Not authorised
|
21-11-2022 |
|
|
VALID
|
|
VOXELOTOR |
B06AX03 |
RO
|
Not authorised
|
21-11-2022 |
|
|
VALID
|
|
ABROCITINIB |
D11AH08 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
ANIFROLUMAB |
L04AG11 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/004975 |
14-02-2022 |
VALID
|
|
ARTESUNATE |
P01BE03 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
ASCIMINIB |
L01EA06 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005605 |
25-08-2022 |
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
CAPMATINIB |
L01EX17 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
FARICIMAB |
S01LA09 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005642 |
15-09-2022 |
VALID
|
|
FOSDENOPTERIN |
A16AX19 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
INEBILIZUMAB |
L04AG10 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
LASMIDITAN |
N02CC08 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
LENACAPAVIR |
J05AX31 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
LONAFARNIB |
A16AX20 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
PRALSETINIB |
L01EX23 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
SOMATROGON |
H01AC08 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005633 |
14-02-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
RO
|
Not authorised
|
18-11-2022 |
|
|
VALID
|
|
TEZEPELUMAB |
R03DX11 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
RO
|
I
|
18-11-2022 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
VARIOUS |
R02AA20 |
RO
|
Not subject to prescription
|
13-07-2022 |
|
|
VALID
|
|
CIPROFLOXACIN |
J01MA02 |
RO
|
I
|
12-07-2022 |
6260 |
|
VALID
|
|
LITHIUM |
N05AN01 |
RO
|
I
|
12-07-2022 |
|
|
VALID
|
|
MOXIFLOXACIN |
J01MA14 |
RO
|
I
|
12-07-2022 |
2487 |
27-02-2002 |
VALID
|
|
NALIDIXIC ACID |
J01MB02 |
RO
|
Not authorised
|
12-07-2022 |
|
|
VALID
|
|
NORFLOXACIN |
J01MA06 |
RO
|
I
|
12-07-2022 |
3039 |
15-01-2003 |
VALID
|
|
OFLOXACIN |
J01MA01 |
RO
|
I
|
12-07-2022 |
3900 |
31-10-2003 |
VALID
|
|
PEFLOXACIN |
J01MA03 |
RO
|
I
|
12-07-2022 |
6953 |
15-04-1998 |
VALID
|
|
THIAMAZOLE |
H03BB02 |
RO
|
II
|
12-07-2022 |
3642 |
23-07-2003 |
VALID
|
|
LOMEFLOXACIN |
S01AE04 |
RO
|
Not authorised
|
11-07-2022 |
|
|
VALID
|
|
FERROUS GLUCONATE |
B03AA03 |
RO
|
II
|
24-06-2022 |
6754 |
02-06-1998 |
VALID
|
|
FERROUS GLYCINE SULFATE |
B03AA01 |
RO
|
Not authorised
|
23-06-2022 |
|
|
VALID
|
|
ACALABRUTINIB |
L01EL02 |
RO
|
I
|
26-04-2022 |
|
|
VALID
|
|
ALPELISIB |
L01EM03 |
RO
|
I
|
25-04-2022 |
|
|
VALID
|
|
DAUNORUBICIN |
L01DB02 |
RO
|
Not authorised
|
25-04-2022 |
|
|
VALID
|
|
ISAVUCONAZOLE |
J02AC05 |
RO
|
I
|
25-04-2022 |
EMEA/H/C/002734 |
15-10-2015 |
VALID
|